Frank Rahmani is a trusted strategic adviser to emerging growth and public companies, investors, and investment banks in the life sciences and technology industries. Drawing on more than two decades of experience advising innovative companies across their full lifecycle from formation through IPO and strategic exit, Frank counsels founders, boards of directors, investors, and underwriters on complex corporate transactions and strategic matters, including venture and growth financings, IPOs and capital market transactions, strategic collaborations, licensing transactions, governance matters, and mergers and acquisitions. Frank is particularly recognized for his work with leading life sciences and technology companies navigating transformative growth, sophisticated financing strategies, and strategic partnering transactions. Frank regularly represents leading investment banks and underwriters in sophisticated public offerings and capital markets transactions. He has represented clients in more than 500 financings and securities offerings and more than 100 strategic collaborations, mergers and acquisitions, and commercial transactions. Frank is ranked in Chambers USA 2025 for Life Sciences: Corporate/Commercial and is recognized by LMG Life Sciences for his work in venture capital and life sciences transactions. Clients describe Frank as "a trusted adviser and critical partner," "extraordinarily experienced and sophisticated," and "an exceptional attorney with a broad and deep knowledge of securities law and transactions involving emerging growth companies."